Purdue Pharma

October 05, 2007 -- Kentucky Attorney General Greg Stumbo today announced the filing of a lawsuit against Purdue Pharma, the manufacturer of OxyContin, a highly abused narcotic.

The lawsuit alleges that Purdue Pharma misrepresented the risks of using OxyContin and seeks to recover damages suffered state and county governments related to widespread addiction caused by the drug.

(Click here for a copy of the Complaint: http://tinyurl.com/2qyfky)    » read more »

September 28, 2007 -- Oregon Attorney General Hardy Myers today announced that the Department of Justice (DOJ) Medicaid Fraud Control Unit has reached a settlement with the Purdue Frederick Company, Inc., a New York Corporation ("Purdue Frederick") and Purdue Pharma L.P., a Delaware limited partnership ("Purdue") which are associated entities engaged in the manufacture, marketing and distribution of OxyContin, an extended-release form of the painkiller Oxycodone.    » read more »

Settlement resolves civil charges caused by company’s misbranding of OxyContin

September 21, 2007 -- TALLAHASSEE, FL – Florida Attorney General Bill McCollum today announced that his Medicaid Fraud Control Unit has joined a national settlement with the Purdue Frederick Company, Inc., a New York corporation, and Purdue Pharma, L.P. a Delaware Limited Partnership. The companies will pay more than $2 million to the State of Florida to resolve civil claims related to the manufacture, marketing and distribution of OxyContin.    » read more »

September 20, 2007 -- (Boise) - The State of Idaho has recovered $652,130 as a result of a civil settlement involving alleged misbranding of the prescription drug OxyContin, Idaho Attorney General Lawrence Wasden said today. Wasden said his office and the Idaho Department of Health and Welfare Medicaid Division joined in a multi-state settlement with two associated businesses engaged in the manufacture, marketing, and distribution of OxyContin, an extended-release form of Oxycodone.    » read more »

September 18, 2007 -- OLYMPIA – Washington Attorney General Rob McKenna announced today that the state's Medicaid program will be reimbursed nearly $2.7 million as part of a settlement with drug manufacturers Purdue Pharma and Purdue Frederick Company. The settlement stems from allegations the company improperly marketed the pain medication OxyContin to health providers.    » read more »

September 18, 2007 -- HARRISBURG - A $5,078,436 settlement has been reached with The Purdue Frederick Company, Inc. and Purdue Pharma, L.P., manufacturers of OxyContin, for improperly marketing the highly addictive pain medication to health care providers.

Pennsylvania Attorney General Tom Corbett said the money is part of a $160 million multi-state civil lawsuit settlement to compensate state and federal Medicaid programs for damages caused by the misbranding of OxyContin from 1995 through 2005.    » read more »

September 18, 2007 -- Carson City, NV - Nevada Attorney General Catherine Cortez Masto announced today that her office has reached a settlement with The Purdue Frederick Company, Inc., a New York corporation, and Purdue Pharma, L.P., a Delaware limited partnership, which are associated entities engaged in the manufacture, marketing, and distribution of OxyContin, an extended-release form of oxycodone.

Under the terms of the settlement, the State of Nevada recovered $1,047,787.19 to recoup damages to the Nevada Medicaid program as well as damages for investigative costs and penalties.    » read more »

September 17, 2007 -- MADISON - Wisconsin's Medicaid Program will be compensated for Purdue Pharmaceuticals' fraudulent practices relating to the sale of OxyContin, Wisconsin Attorney General J.B. Van Hollen announced today. The payment is part of a settlement agreement the Wisconsin Department of Justice (DOJ) and the Wisconsin Department of Health and Family Services (DHFS) have reached with The Purdue Frederick Company, Inc., a New York corporation, and Purdue Pharma, L.P., a Delaware limited partnership (collectively "Purdue").    » read more »

Cuomo’s Medicaid Fraud Control Unit represented NY and 46 other states to disburse funds from $160 million in damages

ALBANY, NY (September 13, 2007) New York Attorney General Andrew M. Cuomo today announced New York State has received $7.26 million in damages from the makers of OxyContin for misrepresenting the dangers of the drug.    » read more »

September 13, 2007 -- Jefferson City, Mo. — Missouri Attorney General Jay Nixon today presented the Missouri Medicaid program with a check in the amount of $2,470,530. The money is the state’s portion of $160 million that prescription drug manufacturer Purdue Pharma agreed to pay to the federal government and state Medicaid programs to compensate them for damages caused by the misbranding of the pain medication OxyContin. The settlement, announced by Nixon on Aug. 14, resolves allegations that Purdue Pharma improperly marketed OxyContin to health care providers using false claims.    » read more »

September 14, 2007 -- LANSING - Michigan Attorney General Mike Cox today announced that he has reached a settlement with The Purdue Frederick Company, Inc. of New York and Purdue Pharma, L.P. of Delaware (collectively "Purdue"), which are associated entities engaged in the manufacture, marketing, and distribution of OxyContin.    » read more »

September 14, 2007 -- BOSTON – Massachusetts Attorney General Martha Coakley’s office has reached a settlement with Purdue Pharma, LP and its subsidiary The Purdue Frederick Company, Inc., whereby the companies have paid $7,981,715.93 to the Massachusetts Medicaid program (MassHealth) to settle claims that Purdue engaged in improper marketing of the highly addictive pain medication OxyContin, resulting in damages to the Commonwealth.    » read more »

July 31, 2007 -- Connecticut Attorney General Richard Blumenthal today, in congressional testimony, demanded federal action on his three-year-old petition to require stronger label warnings on OxyContin and urged stronger criminal sanctions to prevent future tragedy.

More than 300 people have died from OxyContin overdoses, while Purdue Pharma has made hundreds of millions of dollars in profits, Blumenthal said.    » read more »

May 10, 2007 -- Statement of Sidney M. Wolfe, MD, Director, Health Research Group of Public Citizen

The $634 million in criminal and civil penalties - including guilty pleas by three current and former Purdue Frederick executives - for misbranding the potent narcotic Oxycontin, send an important message to the drug industry that this kind of malicious, death-dealing behavior will not be tolerated.

However, the message could have been much stronger.    » read more »

Will Pay $630 Million in Criminal Penalties; Virginia Will Receive Over $60 Million; Additional Funds to be Disbursed Later

May 10, 2007 -- Roanoke - Virginia Attorney General Bob McDonnell, and John L. Brownlee, United States Attorney for the Western District of Virginia, announced today that earlier this morning The Purdue Frederick Company, Inc., along with its President, Chief Legal Officer, and former Chief Medical Officer pleaded guilty to charges of misbranding Purdue’s addictive and highly abusable drug OxyContin.    » read more »